189 related articles for article (PubMed ID: 35225888)
1. Hypomyelinating Leukodystrophy 8 (HLD8)-Associated Mutation of POLR3B Leads to Defective Oligodendroglial Morphological Differentiation Whose Effect Is Reversed by Ibuprofen.
Sawaguchi S; Suzuki R; Oizumi H; Ohbuchi K; Mizoguchi K; Yamamoto M; Miyamoto Y; Yamauchi J
Neurol Int; 2022 Feb; 14(1):212-244. PubMed ID: 35225888
[TBL] [Abstract][Full Text] [Related]
2. Hypomyelinating Leukodystrophy 7 (HLD7)-Associated Mutation of POLR3A Is Related to Defective Oligodendroglial Cell Differentiation, Which Is Ameliorated by Ibuprofen.
Sawaguchi S; Tago K; Oizumi H; Ohbuchi K; Yamamoto M; Mizoguchi K; Miyamoto Y; Yamauchi J
Neurol Int; 2021 Dec; 14(1):11-33. PubMed ID: 35076634
[TBL] [Abstract][Full Text] [Related]
3. Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.
Matsumoto N; Watanabe N; Iibe N; Tatsumi Y; Hattori K; Takeuchi Y; Oizumi H; Ohbuchi K; Torii T; Miyamoto Y; Yamauchi J
Biochem Biophys Rep; 2019 Dec; 20():100705. PubMed ID: 31737794
[TBL] [Abstract][Full Text] [Related]
4. The leukodystrophy mutation Polr3b R103H causes homozygote mouse embryonic lethality and impairs RNA polymerase III biogenesis.
Choquet K; Pinard M; Yang S; Moir RD; Poitras C; Dicaire MJ; Sgarioto N; Larivière R; Kleinman CL; Willis IM; Gauthier MS; Coulombe B; Brais B
Mol Brain; 2019 Jun; 12(1):59. PubMed ID: 31221184
[TBL] [Abstract][Full Text] [Related]
5. Hypomyelinating Leukodystrophy 15 (HLD15)-Associated Mutation of EPRS1 Leads to Its Polymeric Aggregation in Rab7-Positive Vesicle Structures, Inhibiting Oligodendroglial Cell Morphological Differentiation.
Sawaguchi S; Goto M; Kato Y; Tanaka M; Tago K; Oizumi H; Ohbuchi K; Mizoguchi K; Miyamoto Y; Yamauchi J
Polymers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805425
[TBL] [Abstract][Full Text] [Related]
6. Identification of POLR3B biallelic mutations-associated hypomyelinating leukodystrophy-8 in two siblings.
Yang F; Sun H; Yang Y; Wang Y; Dai S; Lin Z; Shen Y; Liu H
Clin Genet; 2023 May; 103(5):596-602. PubMed ID: 36650939
[TBL] [Abstract][Full Text] [Related]
7. PP1C and PP2A are p70S6K Phosphatases Whose Inhibition Ameliorates HLD12-Associated Inhibition of Oligodendroglial Cell Morphological Differentiation.
Matsumoto N; Miyamoto Y; Hattori K; Ito A; Harada H; Oizumi H; Ohbuchi K; Mizoguchi K; Yamauchi J
Biomedicines; 2020 Apr; 8(4):. PubMed ID: 32316234
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Golgi Stress-Responsive Caspase-2 Ameliorates HLD17-Associated AIMP2 Mutant-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation.
Ochiai A; Sawaguchi S; Memezawa S; Seki Y; Morimoto T; Oizumi H; Ohbuchi K; Yamamoto M; Mizoguchi K; Miyamoto Y; Yamauchi J
Neurochem Res; 2022 Sep; 47(9):2617-2631. PubMed ID: 34523057
[TBL] [Abstract][Full Text] [Related]
9. Hypomyelinating Leukodystrophy 10 (HLD10)-Associated Mutations of PYCR2 Form Large Size Mitochondria, Inhibiting Oligodendroglial Cell Morphological Differentiation.
Torii T; Shirai R; Kiminami R; Nishino S; Sato T; Sawaguchi S; Fukushima N; Seki Y; Miyamoto Y; Yamauchi J
Neurol Int; 2022 Dec; 14(4):1062-1080. PubMed ID: 36548190
[TBL] [Abstract][Full Text] [Related]
10. Hypomyelination, hypodontia and craniofacial abnormalities in a Polr3b mouse model of leukodystrophy.
Michell-Robinson MA; Watt KEN; Grouza V; Macintosh J; Pinard M; Tuznik M; Chen X; Darbelli L; Wu CL; Perrier S; Chitsaz D; Uccelli NA; Liu H; Cox TC; Müller CW; Kennedy TE; Coulombe B; Rudko DA; Trainor PA; Bernard G
Brain; 2023 Dec; 146(12):5070-5085. PubMed ID: 37635302
[TBL] [Abstract][Full Text] [Related]
11. Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism.
Daoud H; Tétreault M; Gibson W; Guerrero K; Cohen A; Gburek-Augustat J; Synofzik M; Brais B; Stevens CA; Sanchez-Carpintero R; Goizet C; Naidu S; Vanderver A; Bernard G
J Med Genet; 2013 Mar; 50(3):194-7. PubMed ID: 23355746
[TBL] [Abstract][Full Text] [Related]
12. Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy.
Saitsu H; Osaka H; Sasaki M; Takanashi J; Hamada K; Yamashita A; Shibayama H; Shiina M; Kondo Y; Nishiyama K; Tsurusaki Y; Miyake N; Doi H; Ogata K; Inoue K; Matsumoto N
Am J Hum Genet; 2011 Nov; 89(5):644-51. PubMed ID: 22036171
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Rab7B, But Not of Rab7A, Which Antagonistically Regulates Oligodendroglial Cell Morphological Differentiation, Recovers Tunicamycin-Induced Defective Differentiation in FBD-102b Cells.
Fukushima N; Shirai R; Sato T; Nakamura S; Ochiai A; Miyamoto Y; Yamauchi J
J Mol Neurosci; 2023 Jun; 73(6):363-374. PubMed ID: 37248316
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of Polr3a hypomyelinating leukodystrophy mutations in the S. cerevisiae homolog, RPC160.
Moir RD; Lavados C; Lee J; Willis IM
Gene; 2021 Feb; 768():145259. PubMed ID: 33148458
[TBL] [Abstract][Full Text] [Related]
15. The Infantile Leukoencephalopathy-Associated Mutation of C11ORF73/HIKESHI Proteins Generates de novo Interactive Activity with Filamin A, Inhibiting Oligodendroglial Cell Morphological Differentiation.
Hattori K; Tago K; Memezawa S; Ochiai A; Sawaguchi S; Kato Y; Sato T; Tomizuka K; Ooizumi H; Ohbuchi K; Mizoguchi K; Miyamoto Y; Yamauchi J
Medicines (Basel); 2021 Feb; 8(2):. PubMed ID: 33535532
[TBL] [Abstract][Full Text] [Related]
16. Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy.
Tétreault M; Choquet K; Orcesi S; Tonduti D; Balottin U; Teichmann M; Fribourg S; Schiffmann R; Brais B; Vanderver A; Bernard G
Am J Hum Genet; 2011 Nov; 89(5):652-5. PubMed ID: 22036172
[TBL] [Abstract][Full Text] [Related]
17. Craniofacial features of POLR3-related leukodystrophy caused by biallelic variants in
Mirchi A; Guay SP; Tran LT; Wolf NI; Vanderver A; Brais B; Sylvain M; Pohl D; Rossignol E; Saito M; Moutton S; González-Gutiérrez-Solana L; Thiffault I; Kruer MC; Moron DG; Kauffman M; Goizet C; Sztriha L; Glamuzina E; Melançon SB; Naidu S; Retrouvey JM; Lacombe S; Bernardino-Cuesta B; De Bie I; Bernard G
J Med Genet; 2023 Oct; 60(10):1026-1034. PubMed ID: 37197783
[TBL] [Abstract][Full Text] [Related]
18. Leukodystrophy-associated
Choquet K; Forget D; Meloche E; Dicaire MJ; Bernard G; Vanderver A; Schiffmann R; Fabian MR; Teichmann M; Coulombe B; Brais B; Kleinman CL
J Biol Chem; 2019 May; 294(18):7445-7459. PubMed ID: 30898877
[TBL] [Abstract][Full Text] [Related]
19. POLR3-related leukodystrophy: How do mutations affecting RNA polymerase III subunits cause hypomyelination?
Coulombe B; Derksen A; La Piana R; Brais B; Gauthier MS; Bernard G
Fac Rev; 2021; 10():12. PubMed ID: 33659930
[TBL] [Abstract][Full Text] [Related]
20. Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation.
Choquet K; Yang S; Moir RD; Forget D; Larivière R; Bouchard A; Poitras C; Sgarioto N; Dicaire MJ; Noohi F; Kennedy TE; Rochford J; Bernard G; Teichmann M; Coulombe B; Willis IM; Kleinman CL; Brais B
Mol Brain; 2017 Apr; 10(1):13. PubMed ID: 28407788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
